跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clavoxel-Bid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clavoxel-Bid
Approved
STANDARD
Clavoxel-Bid
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
12bb0b7bc007cfe9
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
12bb0b7bc007cfe9
Drug Approval Philippines Name
Clavoxel-Bid
Product Name
Clavoxel-Bid
Registration Number
DR-XY41086
Brand Name
Clavoxel-Bid
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Suspension
Dosage Strength
457 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Innogen Pharmaceuticals, Inc.
Issuance Date
26 May 2022
Expiry Date
26 July 2027
Pharmacologic Category
Antibacterial (Penicillin/Beta-Lactamse Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
12bb0b7bc007cfe9
Type
Standard
Back to Philippines FDA Approvals